Cargando…

Cell type–specific labeling of newly synthesized proteins by puromycin inactivation

Puromycin and its derivative O-propargyl puromycin (OPP) have recently found widespread use in detecting nascent proteins. Use of these metabolic labels in complex mixtures of cells leads to indiscriminate tagging of nascent proteomes independent of cell type. Here, we show how a widely used mammali...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera-Cabrera, Florencia, Tull, Helena, Capuana, Roberta, Kasvandik, Sergo, Timmusk, Tõnis, Koppel, Indrek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497999/
https://www.ncbi.nlm.nih.gov/pubmed/37543363
http://dx.doi.org/10.1016/j.jbc.2023.105129
_version_ 1785105426486919168
author Cabrera-Cabrera, Florencia
Tull, Helena
Capuana, Roberta
Kasvandik, Sergo
Timmusk, Tõnis
Koppel, Indrek
author_facet Cabrera-Cabrera, Florencia
Tull, Helena
Capuana, Roberta
Kasvandik, Sergo
Timmusk, Tõnis
Koppel, Indrek
author_sort Cabrera-Cabrera, Florencia
collection PubMed
description Puromycin and its derivative O-propargyl puromycin (OPP) have recently found widespread use in detecting nascent proteins. Use of these metabolic labels in complex mixtures of cells leads to indiscriminate tagging of nascent proteomes independent of cell type. Here, we show how a widely used mammalian selection marker, puromycin N-acetyltransferase, can be repurposed for cell-specific metabolic labeling. This approach, which we named puromycin inactivation for cell-selective proteome labeling (PICSL), is based on efficient inactivation of puromycin or OPP in cells expressing puromycin N-acetyltransferase and detection of translation in other cell types. Using cocultures of neurons and glial cells from the rat brain cortex, we show the application of PICSL for puromycin immunostaining, Western blot, and mass spectrometric identification of nascent proteins. By combining PICSL and OPP-mediated proteomics, cell type–enriched proteins can be identified based on reduced OPP labeling in the cell type of interest.
format Online
Article
Text
id pubmed-10497999
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-104979992023-09-14 Cell type–specific labeling of newly synthesized proteins by puromycin inactivation Cabrera-Cabrera, Florencia Tull, Helena Capuana, Roberta Kasvandik, Sergo Timmusk, Tõnis Koppel, Indrek J Biol Chem Methods and Resources Puromycin and its derivative O-propargyl puromycin (OPP) have recently found widespread use in detecting nascent proteins. Use of these metabolic labels in complex mixtures of cells leads to indiscriminate tagging of nascent proteomes independent of cell type. Here, we show how a widely used mammalian selection marker, puromycin N-acetyltransferase, can be repurposed for cell-specific metabolic labeling. This approach, which we named puromycin inactivation for cell-selective proteome labeling (PICSL), is based on efficient inactivation of puromycin or OPP in cells expressing puromycin N-acetyltransferase and detection of translation in other cell types. Using cocultures of neurons and glial cells from the rat brain cortex, we show the application of PICSL for puromycin immunostaining, Western blot, and mass spectrometric identification of nascent proteins. By combining PICSL and OPP-mediated proteomics, cell type–enriched proteins can be identified based on reduced OPP labeling in the cell type of interest. American Society for Biochemistry and Molecular Biology 2023-08-04 /pmc/articles/PMC10497999/ /pubmed/37543363 http://dx.doi.org/10.1016/j.jbc.2023.105129 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Methods and Resources
Cabrera-Cabrera, Florencia
Tull, Helena
Capuana, Roberta
Kasvandik, Sergo
Timmusk, Tõnis
Koppel, Indrek
Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
title Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
title_full Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
title_fullStr Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
title_full_unstemmed Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
title_short Cell type–specific labeling of newly synthesized proteins by puromycin inactivation
title_sort cell type–specific labeling of newly synthesized proteins by puromycin inactivation
topic Methods and Resources
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497999/
https://www.ncbi.nlm.nih.gov/pubmed/37543363
http://dx.doi.org/10.1016/j.jbc.2023.105129
work_keys_str_mv AT cabreracabreraflorencia celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation
AT tullhelena celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation
AT capuanaroberta celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation
AT kasvandiksergo celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation
AT timmusktonis celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation
AT koppelindrek celltypespecificlabelingofnewlysynthesizedproteinsbypuromycininactivation